Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1101517

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1101517

Cannabinoids Market (Product Type: Cannabinoids, Tetrahydrocannabinol, Cannabinol, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795

Add to Cart

The report provides revenue of the global cannabinoids market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cannabinoids market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cannabinoids market.

The report delves into the competitive landscape of the global cannabinoids market. Key players operating in the global cannabinoids market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cannabinoids market profiled in this report.

Product Code: TMRGL84810

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cannabinoids Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Global Cannabinoids Market Analysis and Forecast, 2017-2031
    • 4.3.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PESTLE Analysis
  • 5.3. Cannabis Genetics: Overview & Analysis
  • 5.4. Regulatory Scenario, by Region/Globally
  • 5.5. Pricing Analysis
  • 5.6. List of key Competitors
  • 5.7. COVID-19 Impact Analysis
  • 5.8. Key Industry Development

6. Global Cannabinoids Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Cannabidiol
    • 6.3.2. Tetrahydrocannabinol
    • 6.3.3. Cannabinol
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Cannabinoids Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 7.3.1. Hospitals Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Stores
  • 7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Cannabinoids Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Medicinal Use
      • 8.3.1.1. Chronic Pain
      • 8.3.1.2. Neurological Disorders Management
      • 8.3.1.3. Oncology
      • 8.3.1.4. Others
    • 8.3.2. Non-medical Use
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Cannabinoids Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Cannabinoids Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Cannabidiol
    • 10.2.2. Tetrahydrocannabinol
    • 10.2.3. Cannabinol
    • 10.2.4. Others
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Hospitals Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Stores
  • 10.4. Market Value Forecast, by Application, 2017-2031
    • 10.4.1. Medicinal Use
      • 10.4.1.1. Chronic Pain
      • 10.4.1.2. Neurological Disorders Management
      • 10.4.1.3. Oncology
      • 10.4.1.4. Others
    • 10.4.2. Non-medical Use
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Distribution Channel
    • 10.6.3. By Application
    • 10.6.4. By Country

11. Europe Cannabinoids Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Cannabidiol
    • 11.2.2. Tetrahydrocannabinol
    • 11.2.3. Cannabinol
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.3.1. Hospitals Pharmacies
    • 11.3.2. Retail Pharmacies
    • 11.3.3. Online Stores
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Medicinal Use
      • 11.4.1.1. Chronic Pain
      • 11.4.1.2. Neurological Disorders Management
      • 11.4.1.3. Oncology
      • 11.4.1.4. Others
    • 11.4.2. Non-medical Use
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Distribution Channel
    • 11.6.3. By Application
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Cannabinoids Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Cannabidiol
    • 12.2.2. Tetrahydrocannabinol
    • 12.2.3. Cannabinol
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.3.1. Hospitals Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Stores
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Medicinal Use
      • 12.4.1.1. Chronic Pain
      • 12.4.1.2. Neurological Disorders Management
      • 12.4.1.3. Oncology
      • 12.4.1.4. Others
    • 12.4.2. Non-medical Use
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. Japan
    • 12.5.2. India
    • 12.5.3. Australia & New Zealand
    • 12.5.4. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Distribution Channel
    • 12.6.3. By Application
    • 12.6.4. By Country/Sub-region

13. Latin America Cannabinoids Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Cannabidiol
    • 13.2.2. Tetrahydrocannabinol
    • 13.2.3. Cannabinol
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.3.1. Hospitals Pharmacies
    • 13.3.2. Retail Pharmacies
    • 13.3.3. Online Stores
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Medicinal Use
      • 13.4.1.1. Chronic Pain
      • 13.4.1.2. Neurological Disorders Management
      • 13.4.1.3. Oncology
      • 13.4.1.4. Others
    • 13.4.2. Non-medical Use
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Distribution Channel
    • 13.6.3. By Application
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Cannabinoids Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Cannabidiol
    • 14.2.2. Tetrahydrocannabinol
    • 14.2.3. Cannabinol
    • 14.2.4. Others
  • 14.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.3.1. Hospitals Pharmacies
    • 14.3.2. Retail Pharmacies
    • 14.3.3. Online Stores
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Medicinal Use
      • 14.4.1.1. Chronic Pain
      • 14.4.1.2. Neurological Disorders Management
      • 14.4.1.3. Oncology
      • 14.4.1.4. Others
    • 14.4.2. Non-medical Use
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. South Africa
    • 14.5.2. Israel
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Distribution Channel
    • 14.6.3. By Application
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Mylan N.V. (Viatris Inc.)
      • 15.2.1.1. Company Overview
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. Business Strategies
      • 15.2.1.5. Recent Developments
    • 15.2.2. Alkem Labs
      • 15.2.2.1. Company Overview
      • 15.2.2.2. Financial Overview
      • 15.2.2.3. Product Portfolio
      • 15.2.2.4. Business Strategies
      • 15.2.2.5. Recent Developments
    • 15.2.3. GW Pharmaceuticals plc
      • 15.2.3.1. Company Overview
      • 15.2.3.2. Financial Overview
      • 15.2.3.3. Product Portfolio
      • 15.2.3.4. Business Strategies
      • 15.2.3.5. Recent Developments
    • 15.2.4. Tilray, Inc.
      • 15.2.4.1. Company Overview
      • 15.2.4.2. Financial Overview
      • 15.2.4.3. Product Portfolio
      • 15.2.4.4. Business Strategies
      • 15.2.4.5. Recent Developments
    • 15.2.5. Aurora Cannabis, Inc.
      • 15.2.5.1. Company Overview
      • 15.2.5.2. Financial Overview
      • 15.2.5.3. Product Portfolio
      • 15.2.5.4. Business Strategies
      • 15.2.5.5. Recent Developments
    • 15.2.6. Canopy Growth Corporation
      • 15.2.6.1. Company Overview
      • 15.2.6.2. Financial Overview
      • 15.2.6.3. Product Portfolio
      • 15.2.6.4. Business Strategies
      • 15.2.6.5. Recent Developments
    • 15.2.7. The Cronos Group
      • 15.2.7.1. Company Overview
      • 15.2.7.2. Financial Overview
      • 15.2.7.3. Product Portfolio
      • 15.2.7.4. Business Strategies
      • 15.2.7.5. Recent Developments
Product Code: TMRGL84810

List of Tables

  • Table 01: Global Cannabinoids Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Cannabinoids Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Cannabinoids Market Value (US$ Mn) Forecast, by Medicinal Use, 2017-2031
  • Table 04: Global Cannabinoids Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 05: Global Cannabinoids Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 08: North America Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017-2031
  • Table 09: North America Cannabinoids Market Revenue (US$ Mn) Forecast, by Medicinal Use, 2017-2031
  • Table 10: North America Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 11: Europe Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 13: Europe Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017-2031
  • Table 14: Europe Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 15: Asia Pacific Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Asia Pacific Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 17: Asia Pacific Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017-2031
  • Table 18: Asia Pacific Cannabinoids Market Revenue (US$ Mn) Forecast, by Application (Medicinal Use), 2017-2031
  • Table 19: Asia Pacific Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Latin America Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Latin America Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 22: Latin America Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Latin America Cannabinoids Market Revenue (US$ Mn) Forecast, by Application (Medicinal Use), 2017-2031
  • Table 24: Latin America Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 25: Middle East & Africa Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Middle East & Africa Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 27: Middle East & Africa Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017-2031
  • Table 28: Middle East & Africa Cannabinoids Market Revenue (US$ Mn) Forecast, by Application (Medicinal Use), 2017-2031
  • Table 29: Middle East & Africa Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Cannabinoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 02: Global Cannabinoids Market Value Share (%), by Region, 2020
  • Figure 03: Global Cannabinoids Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 04: Global Cannabinoids Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 05: Global Cannabinoids Market Value (US$ Mn), by Cannabidiol, 2017-2031
  • Figure 06: Global Cannabinoids Market Value (US$ Mn), by Tetrahydrocannabinol, 2017-2031
  • Figure 07: Global Cannabinoids Market Value (US$ Mn), by Cannabinol, 2017-2031
  • Figure 08: Global Cannabinoids Market Value (US$ Mn), by Others, 2017-2031
  • Figure 09: Global Cannabinoids Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 10: Global Cannabinoids Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 11: Global Cannabinoids Market Revenue (US$ Mn), by Medicinal Use, 2017-2031
  • Figure 12: Global Cannabinoids Market Revenue (US$ Mn), by Non-medical Use, 2017-2031
  • Figure 13: Global Cannabinoids Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 14: Global Cannabinoids Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 15: Global Cannabinoids Market Revenue (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 16: Global Cannabinoids Market Revenue (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 17: Global Cannabinoids Market Revenue (US$ Mn), by Online Stores, 2017-2031
  • Figure 18: Global Cannabinoids Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 19: Global Cannabinoids Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 20: North America Cannabinoids Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 21: North America Cannabinoids Market Analysis Value Share Analysis, by Country, 2020 and 2031
  • Figure 22: North America Cannabinoids Market Analysis Attractiveness Analysis, by Country 2021-2031
  • Figure 23: North America Cannabinoids Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 24: North America Cannabinoids Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 25: North America Cannabinoids Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 26: North America Cannabinoids Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 27: North America Cannabinoids Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 28: North America Cannabinoids Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 29: Europe Cannabinoids Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: Europe Cannabinoids Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 31: Europe Cannabinoids Market Analysis Attractiveness Analysis, by Country/Sub-region 2021-2031
  • Figure 32: Europe Cannabinoids Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 33: Europe Cannabinoids Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 34: Europe Cannabinoids Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 35: Europe Cannabinoids Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 36: Europe Cannabinoids Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 37: Europe Cannabinoids Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 38: Asia Pacific Cannabinoids Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 39: Asia Pacific Cannabinoids Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 40: Asia Pacific Cannabinoids Market Analysis Attractiveness Analysis, by Country/Sub-region 2021-2031
  • Figure 41: Asia Pacific Cannabinoids Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 42: Asia Pacific Cannabinoids Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 43: Asia Pacific Cannabinoids Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 44: Asia Pacific Cannabinoids Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 45: Asia Pacific Cannabinoids Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 46: Asia Pacific Cannabinoids Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 47: Latin America Cannabinoids Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 48: Latin America Cannabinoids Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 49: Latin America Cannabinoids Market Analysis Attractiveness Analysis, by Country/Sub-region 2021-2031
  • Figure 50: Latin America Cannabinoids Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 51: Latin America Cannabinoids Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 52: Latin America Cannabinoids Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 53: Latin America Cannabinoids Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 54: Latin America Cannabinoids Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 55: Latin America Cannabinoids Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 56: Middle East & Africa Cannabinoids Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 57: Middle East & Africa Cannabinoids Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 58: Middle East & Africa Cannabinoids Market Analysis Attractiveness Analysis, by Country/Sub-region 2021-2031
  • Figure 59: Middle East & Africa Cannabinoids Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 60: Middle East & Africa Cannabinoids Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 61: Middle East & Africa Cannabinoids Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 62: Middle East & Africa Cannabinoids Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 63: Middle East & Africa Cannabinoids Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 64: Middle East & Africa Cannabinoids Market Attractiveness Analysis, by Distribution Channel, 2021-2031
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!